New York · 2025 Regular Session · Bill
S 5260: Relates to patient counseling before issuing a prescription for a schedule II opioid
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
S 5260 is a bill introduced in the New York Senate on February 20, 2025. According to its official title, it concerns: Relates to patient counseling before issuing a prescription for a schedule II opioid. Primary sponsor: Jake Ashby (Republican/Conservative). Most recent recorded action (January 7, 2026): REFERRED TO HEALTH.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official summary
Abstract published by the legislature (via Open States). Text as published by the legislature; reproduced verbatim.
Relates to patient counseling before issuing a prescription for a schedule II opioid; requires practitioners to consult with the patient regarding the quantity of the opioid and the patient's option to fill the prescription in a lesser quantity, and to inform the patient of the risks associated with opiate addiction and document the reason for the prescription.
Sponsors
Sponsors by party (alphabetical): Republican/Conservative 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Jake Ashby | Primary sponsor | Republican/Conservative | Senate | 43 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- REFERRED TO HEALTH
- REFERRED TO HEALTH